Literature DB >> 9274624

Role of protein kinases in the in vitro differentiation of human epidermal HaCaT cells.

J M Paramio1, J L Jorcano.   

Abstract

Different chemicals that specifically and selectively inhibit or activate protein kinases have been used to define the possible roles of these enzymes in the different steps of epidermal differentiation. Using HaCaT keratinocytes as a model, and under conditions in which cell proliferation is minimally affected, we found that tyrosine kinase inhibition leads to an inhibition of early (spinous; keratin k10 expression) and late (granulosum; involucrin expression) differentiation processes. cGMP- and cAMP-dependent protein kinases appear to modulate the transition from spinous to granular differentiation, a process which seems to be negatively controlled by protein phosphatases. Finally, enzymes belonging to the protein kinase C family appear to facilitate the transition from spinous to granular differentiation programmes while inhibiting the early steps of epidermal differentiation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9274624

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  3 in total

1.  Modulation of cell proliferation by cytokeratins K10 and K16.

Authors:  J M Paramio; M L Casanova; C Segrelles; S Mittnacht; E B Lane; J L Jorcano
Journal:  Mol Cell Biol       Date:  1999-04       Impact factor: 4.272

2.  Inhibition of protein kinase B (PKB) and PKCzeta mediates keratin K10-induced cell cycle arrest.

Authors:  J M Paramio; C Segrelles; S Ruiz; J L Jorcano
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

3.  Matrix metalloproteinase 19 regulates insulin-like growth factor-mediated proliferation, migration, and adhesion in human keratinocytes through proteolysis of insulin-like growth factor binding protein-3.

Authors:  Thorsten Sadowski; Sebastian Dietrich; Felix Koschinsky; Radislav Sedlacek
Journal:  Mol Biol Cell       Date:  2003-08-22       Impact factor: 4.138

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.